Steven Burke
Net worth: 532 856 $ as of 31/08/2026
Net worth: 532 856 $ as of 31/08/2026
Dr. Steven K.
Burke, MD, is a Chief Medical, Research & Development Officer at Akebia Therapeutics, Inc. He is on the Board of Directors at SCYNEXIS, Inc., AbFero Pharmaceuticals, Inc. and LeukoSight, Inc. Dr. Burke was previously employed as a Chief Medical Officer & Senior Vice President by Proteon Therapeutics, Inc., a Senior Vice President-Medical & Regulatory Affairs by Genzyme Corp., a Medical Director & VP-Clinical Research by GelTex Pharmaceuticals, Inc., an Associate Director-Clinical Research by Glaxo, Inc., and a Chief Medical Officer by Protara Therapeutics, Inc. He received his undergraduate degree from Harvard College and a doctorate degree from Weill Cornell Medical College.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 31/03/2026 | 5,47,098 ( 0.2% ) | 502 783 $ | 31/08/2026 | |
SCYNEXIS, INC. 0.06% | 18/09/2026 | 5,750 ( 0.06% ) | 30 073 $ | 31/08/2026 |
| Companies | Position | Start |
|---|---|---|
| AKEBIA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 17/06/2019 |
| SCYNEXIS, INC. | Director/Board Member | 18/09/2026 |
LeukoSight, Inc.
LeukoSight, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics to treat autoimmune and inflammatory diseases | Director/Board Member | - |
| Companies | Position | End |
|---|---|---|
| PROTARA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/01/2019 |
GelTex Pharmaceuticals, Inc.
GelTex Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops non-absorbed, polymer-based pharmaceuticals | Chief Tech/Sci/R&D Officer | 01/01/2001 |
AbFero Pharmaceuticals, Inc.
AbFero Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops oral iron chelators for the treatment of diseases of iron overload | Founder | - |
| PROTARA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Glaxo, Inc. | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 11 |
|---|---|
GelTex Pharmaceuticals, Inc.
GelTex Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops non-absorbed, polymer-based pharmaceuticals | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Proteon Therapeutics, Inc.
Proteon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops pharmaceuticals products for patients with renal and vascular disease | Health Technology |
SCYNEXIS, Inc.
SCYNEXIS, Inc. Pharmaceuticals: MajorHealth Technology Develops novel oral and intravenous triterpenoid antifungal for the treatment of several serious fungal infections | Health Technology |
Akebia Therapeutics, Inc.
Akebia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for kidney diseases | Health Technology |
Glaxo, Inc. | |
LeukoSight, Inc.
LeukoSight, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics to treat autoimmune and inflammatory diseases | Health Technology |
Weill Cornell Medical College
Weill Cornell Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard College
Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AbFero Pharmaceuticals, Inc.
AbFero Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops oral iron chelators for the treatment of diseases of iron overload | Health Technology |
Protara Therapeutics, Inc.
Protara Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Select your edition
All financial news and data tailored to specific country editions